Literature DB >> 9537235

Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer.

G R Bignell1, R Barfoot, S Seal, N Collins, W Warren, M R Stratton.   

Abstract

Germ-line mutations in the LKB1 gene on chromosome 19p are responsible for most cases of the Peutz-Jeghers syndrome, in which intestinal hamartomas are associated with elevated risks of several cancer types, including breast cancer. We have evaluated the role of somatic mutations in LKB1 in breast cancer. Of 40 informative primary breast cancers, 3 showed loss of heterozygosity on chromosome 19p in the vicinity of LKB1, and no somatic mutations of LKB1 were observed in 62 primary breast cancers and 17 established breast cancer cell lines. The results indicate that mutations in LKB1 do not play an important role in the development of sporadic breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9537235

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome.

Authors:  D C Connolly; H Katabuchi; W A Cliby; K R Cho
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

3.  Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity.

Authors:  Johanna I Partanen; Topi A Tervonen; Mikko Myllynen; Essi Lind; Misa Imai; Pekka Katajisto; Gerrit J P Dijkgraaf; Panu E Kovanen; Tomi P Mäkelä; Zena Werb; Juha Klefström
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

Review 4.  Germinal center kinases in immune regulation.

Authors:  Hailei Yin; Zhubing Shi; Shi Jiao; Cuicui Chen; Wenjia Wang; Mark I Greene; Zhaocai Zhou
Journal:  Cell Mol Immunol       Date:  2012-09-10       Impact factor: 11.530

5.  LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.

Authors:  S P Collins; J L Reoma; D M Gamm; M D Uhler
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

6.  Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients.

Authors:  Z J Wang; M Churchman; E Avizienyte; C McKeown; S Davies; D G Evans; A Ferguson; I Ellis; W H Xu; Z Y Yan; L A Aaltonen; I P Tomlinson
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

7.  STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  N Sato; C Rosty; M Jansen; N Fukushima; T Ueki; C J Yeo; J L Cameron; C A Iacobuzio-Donahue; R H Hruban; M Goggins
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

8.  Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.

Authors:  G H Su; R H Hruban; R K Bansal; G S Bova; D J Tang; M C Shekher; A M Westerman; M M Entius; M Goggins; C J Yeo; S E Kern
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

9.  No association between promoter polymorphism of STK11 gene and lung cancer risk in the Korean population.

Authors:  Jae Sook Sung; Young Mi Whang; Kyong Hwa Park; Jeong-Seon Ryu; Jong Gwon Choi; Jae Hong Seo; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim
Journal:  Cancer Res Treat       Date:  2009-12-31       Impact factor: 4.679

10.  Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity.

Authors:  H Mehenni; C Gehrig; J Nezu; A Oku; M Shimane; C Rossier; N Guex; J L Blouin; H S Scott; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.